Pregnancy: DUOFLOW is contraindicated for use by women.
Dutasteride: Dutasteride has not been studied in women because pre-clinical data suggests that the suppression of circulating levels of dihydrotestosterone may inhibit the development of the external genital organs in a male foetus carried by a woman exposed to dutasteride.
Tamsulosin: Administration of tamsulosin hydrochloride to pregnant female rats and rabbits at higher than the therapeutic dose showed no evidence of foetal harm.
Lactation: DUOFLOW is contraindicated for use in women.
It is not known whether dutasteride or tamsulosin are excreted in breast milk.
Other Services
Country
Account